{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:04Z","timestamp":1794047404859,"version":"4.8.0"},"reference-count":54,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"10","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Anemia of cancer (AoC) with its multifactorial etiology and complex pathology is a poor prognostic indicator for cancer patients. One of the main causes of AoC is cancer-associated inflammation that activates mechanisms, commonly observed in anemia of inflammation, whereby functional iron deficiency and iron-restricted erythropoiesis are induced by increased hepcidin levels in response to raised levels of interleukin-6. So far only a few AoC mouse models have been described, and most of them did not fully recapitulate the interplay of anemia, increased hepcidin levels and functional iron deficiency in human patients. To test if the selection and the complexity of AoC mouse models dictates the pathology or if AoC in mice per se develops independently of iron deficiency, we characterized AoC in Trp53floxWapCre mice that spontaneously develop breast cancer. These mice developed AoC associated with high levels of interleukin-6 and iron deficiency. However, hepcidin levels were not increased and hypoferremia coincided with anemia rather than causing it. Instead, an early shift in the commitment of common myeloid progenitors from the erythroid to the myeloid lineage resulted in increased myelopoiesis and in the excessive production of neutrophils that accumulate in necrotic tumor regions. This process could not be prevented by either iron or erythropoietin treatment. Trp53floxWapCre mice are the first mouse model in which erythropoietin-resistant anemia is described and may serve as a disease model to test therapeutic approaches for a subpopulation of human cancer patients with normal or corrected iron levels who do not respond to erythropoietin.<\/jats:p>","DOI":"10.3324\/haematol.2022.280732","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T03:06:44Z","timestamp":1649300804000},"page":"2454-2465","source":"Crossref","is-referenced-by-count":7,"title":["Iron- and erythropoietin-resistant anemia in a spontaneous breast cancer mouse model"],"prefix":"10.3324","volume":"107","author":[{"given":"Nuria Fabregas","family":"Bregolat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Ruetten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milene Costa","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa A.","family":"Aboouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyrije","family":"Ademi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine von","family":"B\u00fcren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Armbruster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Stirn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Altamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M. Monn\u00e9","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Samillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashim Pal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Wielockx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina U.","family":"Muckenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Gassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Thiersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"40537","doi-asserted-by":"crossref","unstructured":"Gilreath JA, Stenehjem DD, Rodgers GM. Diagnosis and treatment of cancer-related anemia. Am J Hematol. 2014; 89(2):203-212.","DOI":"10.1002\/ajh.23628"},{"key":"40538","doi-asserted-by":"crossref","unstructured":"Zhang Y, Chen Y, Chen D. Impact of preoperative anemia on relapse and survival in breast cancer patients. BMC Cancer. 2014; 14:844.","DOI":"10.1186\/1471-2407-14-844"},{"key":"40539","doi-asserted-by":"crossref","unstructured":"Nemeth E, Rivera S, Gabayan V. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113(9):1271-1276.","DOI":"10.1172\/JCI200420945"},{"key":"40540","doi-asserted-by":"crossref","unstructured":"Pigeon C, Ilyin G, Courselaud B. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001; 276(11):7811-7819.","DOI":"10.1074\/jbc.M008923200"},{"key":"40541","doi-asserted-by":"crossref","unstructured":"Rivera S, Nemeth E, Gabayan V. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005; 106(6):2196-2199.","DOI":"10.1182\/blood-2005-04-1766"},{"key":"40542","doi-asserted-by":"crossref","unstructured":"Andriopoulos B, Corradini E, Xia Y. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009; 41(4):482-487.","DOI":"10.1038\/ng.335"},{"key":"40543","doi-asserted-by":"crossref","unstructured":"Kautz L, Meynard D, Monnier A. Iron regulates phosphorylation of Smad1\/5\/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood. 2008; 112(4):1503-1509.","DOI":"10.1182\/blood-2008-03-143354"},{"key":"40544","doi-asserted-by":"crossref","unstructured":"Kautz L, Jung G, Valore EV. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014; 46(7):678-684.","DOI":"10.1038\/ng.2996"},{"key":"40545","doi-asserted-by":"crossref","unstructured":"Muckenthaler MU, Rivella S, Hentze MW. A red carpet for iron metabolism. Cell. 2017; 168(3):344-361.","DOI":"10.1016\/j.cell.2016.12.034"},{"key":"40546","doi-asserted-by":"crossref","unstructured":"Wang CY, Xu Y, Traeger L. Erythroferrone lowers hepcidin by sequestering BMP2\/6 heterodimer from binding to the BMP type I receptor ALK3. Blood. 2020; 135(6):453-456.","DOI":"10.1182\/blood.2019002620"},{"key":"40547","doi-asserted-by":"crossref","unstructured":"Gassmann M, Muckenthaler MU. Adaptation of iron requirement to hypoxic conditions at high altitude. J Appl Physiol (1985). 2015; 119(12):1432-1440.","DOI":"10.1152\/japplphysiol.00248.2015"},{"key":"40548","doi-asserted-by":"crossref","unstructured":"Nemeth E, Tuttle MS, Powelson J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306(5704):2090-2093.","DOI":"10.1126\/science.1104742"},{"key":"40549","doi-asserted-by":"crossref","unstructured":"Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012; 1823(9):1434-1443.","DOI":"10.1016\/j.bbamcr.2012.01.014"},{"key":"40550","doi-asserted-by":"crossref","unstructured":"Cheng Z, Yan M, Lu Y. Expression of serum BMP6 and hepcidin in cancer-related anemia. Hematology. 2020; 25(1):134-138.","DOI":"10.1080\/16078454.2020.1738098"},{"key":"40551","doi-asserted-by":"crossref","unstructured":"Maccio A, Madeddu C, Gramignano G. The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica. 2015; 100(1):124-132.","DOI":"10.3324\/haematol.2014.112813"},{"key":"40552","doi-asserted-by":"crossref","unstructured":"Kim A, Rivera S, Shprung D. Mouse models of anemia of cancer. PLoS One. 2014; 9(3):e93283.","DOI":"10.1371\/journal.pone.0093283"},{"key":"40553","doi-asserted-by":"crossref","unstructured":"Mori K, Fujimoto-Ouchi K, Onuma E. Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells. Biomed Res. 2009; 30(1):47-51.","DOI":"10.2220\/biomedres.30.47"},{"key":"40554","doi-asserted-by":"crossref","unstructured":"Noguchi-Sasaki M, Sasaki Y, Shimonaka Y. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells. BMC Cancer. 2016; 16:270.","DOI":"10.1186\/s12885-016-2305-2"},{"key":"40555","doi-asserted-by":"crossref","unstructured":"Rizzo JD, Brouwers M, Hurley P. American Society of Clinical Oncology\/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Oncol Pract. 2010; 6(6):317-320.","DOI":"10.1200\/JOP.2010.000132"},{"key":"40556","doi-asserted-by":"crossref","unstructured":"Akchurin O, Patino E, Dalal V. Interleukin-6 contributes to the development of anemia in juvenile CKD. Kidney Int Rep. 2019; 4(3):470-483.","DOI":"10.1016\/j.ekir.2018.12.006"},{"key":"40557","doi-asserted-by":"crossref","unstructured":"McCranor BJ, Kim MJ, Cruz NM. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. Blood Cells Mol Dis. 2014; 52(2-3):126-133.","DOI":"10.1016\/j.bcmd.2013.09.004"},{"key":"40558","doi-asserted-by":"crossref","unstructured":"Liu YX, Dong X, Gong F. Promotion of erythropoietic differentiation in hematopoietic stem cells by SOCS3 knock-down. PLoS One. 2015; 10(8):e0135259.","DOI":"10.1371\/journal.pone.0135259"},{"key":"40559","doi-asserted-by":"crossref","unstructured":"Rusten LS, Jacobsen SE. Tumor necrosis factor (TNF)-alpha directly inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors. Blood. 1995; 85(4):989-996.","DOI":"10.1182\/blood.V85.4.989.bloodjournal854989"},{"key":"40560","doi-asserted-by":"crossref","unstructured":"Libregts SF, Gutierrez L, de Bruin AM. Chronic IFN-gamma production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1\/PU.1 axis. Blood. 2011; 118(9):2578-2588.","DOI":"10.1182\/blood-2010-10-315218"},{"key":"40561","doi-asserted-by":"crossref","unstructured":"DuPre SA, Hunter KW. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol. 2007; 82(1):12-24.","DOI":"10.1016\/j.yexmp.2006.06.007"},{"key":"40562","doi-asserted-by":"crossref","unstructured":"Liu M, Jin X, He X. Macrophages support splenic erythropoiesis in 4T1 tumor-bearing mice. PLoS One. 2015; 10(3):e0121921.","DOI":"10.1371\/journal.pone.0121921"},{"key":"40563","doi-asserted-by":"crossref","unstructured":"Chen K, Liu J, Heck S. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci U S A. 2009; 106(41):17413-17418.","DOI":"10.1073\/pnas.0909296106"},{"key":"40564","doi-asserted-by":"crossref","unstructured":"Pronk CJ, Rossi DJ, Mansson R. Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell. 2007; 1(4):428-442.","DOI":"10.1016\/j.stem.2007.07.005"},{"key":"40565","doi-asserted-by":"crossref","unstructured":"Sonnweber T, Nachbaur D, Schroll A. Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB. Gut. 2014; 63(12):1951-1959.","DOI":"10.1136\/gutjnl-2013-305317"},{"key":"40566","doi-asserted-by":"crossref","unstructured":"Singh RP, Grinenko T, Ramasz B. Hematopoietic stem cells but not multipotent progenitors drive erythropoiesis during chronic rrythroid stress in EPO transgenic mice. Stem Cell Reports. 2018; 10(6):1908-1919.","DOI":"10.1016\/j.stemcr.2018.04.012"},{"key":"40567","doi-asserted-by":"crossref","unstructured":"Broudy VC, Lin NL, Priestley GV. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Blood. 1996; 88(1):75-81.","DOI":"10.1182\/blood.V88.1.75.75"},{"key":"40568","doi-asserted-by":"crossref","unstructured":"Mortensen M, Ferguson DJ, Edelmann M. Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo. Proc Natl Acad Sci U S A. 2010; 107(2):832-837.","DOI":"10.1073\/pnas.0913170107"},{"key":"40569","doi-asserted-by":"crossref","unstructured":"Tonia T, Mettler A, Robert N. Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev. 2012; 12:CD003407.","DOI":"10.1002\/14651858.CD003407.pub5"},{"key":"40570","doi-asserted-by":"crossref","unstructured":"Langdon JM, Yates SC, Femnou LK. Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation. Am J Hematol. 2014; 89(5):470-479.","DOI":"10.1002\/ajh.23670"},{"key":"40571","doi-asserted-by":"crossref","unstructured":"Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood. 2016; 127(23):2809-2813.","DOI":"10.1182\/blood-2015-12-639112"},{"key":"40572","doi-asserted-by":"crossref","unstructured":"Lasocki S, Millot S, Andrieu V. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med. 2008; 36(8):2388-2394.","DOI":"10.1097\/CCM.0b013e31818103b9"},{"key":"40573","doi-asserted-by":"crossref","unstructured":"Theurl I, Aigner E, Theurl M. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009; 113(21):5277-5286.","DOI":"10.1182\/blood-2008-12-195651"},{"key":"40574","doi-asserted-by":"crossref","unstructured":"Duarte TL, Talbot NP, Drakesmith H. NRF2 and hypoxia-inducible factors: key players in the redox control of systemic iron homeostasis. Antioxid Redox Signal. 2021; 35(6):433-452.","DOI":"10.1089\/ars.2020.8148"},{"key":"40575","doi-asserted-by":"crossref","unstructured":"Liu Q, Davidoff O, Niss K. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest. 2012; 122(12):4635-4644.","DOI":"10.1172\/JCI63924"},{"key":"40576","unstructured":"Ganzoni AM. [Intravenous iron-dextran: therapeutic and experimental possibilities]. Schweiz Med Wochenschr. 1970; 100(7):301-303."},{"key":"40577","doi-asserted-by":"crossref","unstructured":"Pfeifhofer-Obermair C, Tymoszuk P, Petzer V. Iron in the tumor microenvironment - connecting the dots. Front Oncol. 2018; 8:549.","DOI":"10.3389\/fonc.2018.00549"},{"key":"40578","doi-asserted-by":"crossref","unstructured":"Prince OD, Langdon JM, Layman AJ. Late stage erythroid precursor production is impaired in mice with chronic inflammation. Haematologica. 2012; 97(11):1648-1656.","DOI":"10.3324\/haematol.2011.053397"},{"key":"40579","doi-asserted-by":"crossref","unstructured":"Akashi K, Traver D, Miyamoto T. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000; 404(6774):193-197.","DOI":"10.1038\/35004599"},{"key":"40580","doi-asserted-by":"crossref","unstructured":"Tabuchi T, Ubukata H, Saniabadi AR. Granulocyte apheresis as a possible new approach in cancer therapy: a pilot study involving two cases. Cancer Detect Prev. 1999; 23(5):417-421.","DOI":"10.1046\/j.1525-1500.1999.99029.x"},{"key":"40581","doi-asserted-by":"crossref","unstructured":"He H, Zhang Z, Ge J. Leukemoid reaction associated with transitional cell carcinoma: a case report and literature review. Niger J Clin Pract. 2014; 17(3):391-394.","DOI":"10.4103\/1119-3077.130256"},{"key":"40582","unstructured":"Lan S, Rettura G, Levenson SM. Granulopoiesis associated with the C3HBA tumor in mice. J Natl Cancer Inst. 1981; 67(5):1135-1138."},{"key":"40583","unstructured":"Thomas E, Smith DC, Lee MY. Induction of granulocytic hyperplasia, thymic atrophy, and hypercalcemia by a selected subpopulation of a murine mammary adenocarcinoma. Cancer Res. 1985; 45(11 Pt 2):5840-5844."},{"key":"40584","doi-asserted-by":"crossref","unstructured":"Jacobsen RN, Forristal CE, Raggatt LJ. Mobilization with granulocyte colony-stimulating factor blocks medullar erythropoiesis by depleting F4\/80(+)VCAM1(+)CD169(+)ER-HR3(+)Ly6G(+) erythroid island macrophages in the mouse. Exp Hematol. 2014; 42(7):547-561e4.","DOI":"10.1016\/j.exphem.2014.03.009"},{"key":"40585","unstructured":"Bahar B, Acedil Ayc Iota B, Coskun U. Granulocyte colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) as potential tumor markers in non small cell lung cancer diagnosis. Asian Pac J Cancer Prev. 2010; 11(3):709-712."},{"key":"40586","doi-asserted-by":"crossref","unstructured":"Curran CS, Evans MD, Bertics PJ. GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation. J Immunol. 2011; 187(3):1254-1263.","DOI":"10.4049\/jimmunol.1001965"},{"key":"40587","doi-asserted-by":"crossref","unstructured":"Zsebo KM, Williams DA, Geissler EN. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell. 1990; 63(1):213-224.","DOI":"10.1016\/0092-8674(90)90302-U"},{"key":"40588","doi-asserted-by":"crossref","unstructured":"Park S, Jung CW, Kim K. Iron deficient erythropoiesis might play key role in development of anemia in cancer patients. Oncotarget. 2015; 6(40):42803-42812.","DOI":"10.18632\/oncotarget.5658"},{"key":"40589","doi-asserted-by":"crossref","unstructured":"Shu T, Jing C, Lv Z. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis. Eur J Haematol. 2015; 94(1):67-73.","DOI":"10.1111\/ejh.12402"},{"key":"40590","doi-asserted-by":"crossref","unstructured":"Small T, Oski FA. The mean corpuscular volume (MCV) in children with acute lymphoblastic leukemia. Clin Pediatr (Phila). 1979; 18(11):687-688.","DOI":"10.1177\/000992287901801104"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.280732\/74352","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.280732\/74897","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10598\/74352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:01:27Z","timestamp":1794045687000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.280732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.280732","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,7]]}}}